| Vaccine |
HPV type |
Country* |
Year Implemented |
| Cervarix®, GlaxoSmithKline (GSK) |
16, 18 |
USA, Australia, Europe |
2007 |
| Gardasil®, Merck |
6, 11, 16, 18 |
USA, Canada, South Korea,
New Zealand, Mexico
United Kingdom |
2007
2008
2012 |
| Cervarix®, GSK/ Gardasil®, Merck |
- |
Ghana, Kenya, Magadascar,
Malawi, Niger, Sierra Leone,
Tanzania |
2013 |
| V503*, Merck (phase 3 clinical trial) |
6, 11, 16, 18, 31, 33,
45, 52, 58 |
|
*Pending FDA approval |
*This list is not meant to be exhaustive |
